These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2211372)
41. Azithromycin-sulfonamide conjugates as inhibitors of resistant Streptococcus pyogenes strains. Bukvić Krajacić M; Novak P; Cindrić M; Brajsa K; Dumić M; Kujundzić N Eur J Med Chem; 2007 Feb; 42(2):138-45. PubMed ID: 17011079 [TBL] [Abstract][Full Text] [Related]
42. Structure-activity relationships of novel alkylides: 3-O-arylalkyl clarithromycin derivatives with improved antibacterial activities. Liang JH; Li XL; Wang H; An K; Wang YY; Xu YC; Yao GW Eur J Med Chem; 2012 Mar; 49():289-303. PubMed ID: 22301216 [TBL] [Abstract][Full Text] [Related]
43. Synthesis and antibacterial activity of alkyl derivatives of the glycopeptide antibiotic A40926 and their amides. Maffioli SI; Ciabatti R; Romanò G; Marzorati E; Preobrazhenskaya M; Pavlov A Bioorg Med Chem Lett; 2005 Aug; 15(16):3801-5. PubMed ID: 15993054 [TBL] [Abstract][Full Text] [Related]
44. Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens. Huang X; Bao Y; Zhu S; Zhang X; Lan S; Wang T Bioorg Med Chem Lett; 2015 Sep; 25(18):3928-32. PubMed ID: 26238324 [TBL] [Abstract][Full Text] [Related]
45. Novel cyclohexyl-amides as potent antibacterials targeting bacterial type IIA topoisomerases. Miles TJ; Barfoot C; Brooks G; Brown P; Chen D; Dabbs S; Davies DT; Downie DL; Eyrisch S; Giordano I; Gwynn MN; Hennessy A; Hoover J; Huang J; Jones G; Markwell R; Rittenhouse S; Xiang H; Pearson N Bioorg Med Chem Lett; 2011 Dec; 21(24):7483-8. PubMed ID: 22030032 [TBL] [Abstract][Full Text] [Related]
46. Synthesis and antibacterial activity of novel water-soluble nocathiacin analogs. Xu L; Farthing AK; Dropinski JF; Meinke PT; McCallum C; Hickey E; Liu K Bioorg Med Chem Lett; 2013 Jan; 23(1):366-9. PubMed ID: 23164707 [TBL] [Abstract][Full Text] [Related]
47. Novel lbeta-methylcarbapenems having cyclic sulfonamide moieties: synthesis and evaluation of in vitro antibacterial activity. Kim SJ; Park HB; Lee JS; Jo NH; Yoo KH; Baek D; Kang BW; Cho JH; Oh CH Eur J Med Chem; 2007 Sep; 42(9):1176-83. PubMed ID: 17418453 [TBL] [Abstract][Full Text] [Related]
48. Synthesis and in vitro antibacterial activity of new steroidal thiosemicarbazone derivatives. Khan SA; Kumar P; Joshi R; Iqbal PF; Saleem K Eur J Med Chem; 2008 Sep; 43(9):2029-34. PubMed ID: 18450330 [TBL] [Abstract][Full Text] [Related]
49. Organization of the biosynthetic genes encoding deoxyactagardine B (DAB), a new lantibiotic produced by Actinoplanes liguriae NCIMB41362. Boakes S; Appleyard AN; Cortés J; Dawson MJ J Antibiot (Tokyo); 2010 Jul; 63(7):351-8. PubMed ID: 20520597 [TBL] [Abstract][Full Text] [Related]
50. Synthesis and antibacterial activity of various substituted s-triazines. Srinivas K; Srinivas U; Bhanuprakash K; Harakishore K; Murthy US; Rao VJ Eur J Med Chem; 2006 Nov; 41(11):1240-6. PubMed ID: 16815597 [TBL] [Abstract][Full Text] [Related]
51. Synthesis, antiproliferative and antibacterial activity of new amides of salinomycin. Antoszczak M; Maj E; Stefańska J; Wietrzyk J; Janczak J; Brzezinski B; Huczyński A Bioorg Med Chem Lett; 2014 Apr; 24(7):1724-9. PubMed ID: 24631190 [TBL] [Abstract][Full Text] [Related]
52. New insights into the mode of action of the lantibiotic salivaricin B. Barbour A; Tagg J; Abou-Zied OK; Philip K Sci Rep; 2016 Aug; 6():31749. PubMed ID: 27526944 [TBL] [Abstract][Full Text] [Related]
54. Nucleotide sequence of the streptococcin A-FF22 lantibiotic regulon: model for production of the lantibiotic SA-FF22 by strains of Streptococcus pyogenes. McLaughlin RE; Ferretti JJ; Hynes WL FEMS Microbiol Lett; 1999 Jun; 175(2):171-7. PubMed ID: 10386366 [TBL] [Abstract][Full Text] [Related]
55. Carboxyl Analogue of Mutacin 1140, a Scaffold for Lead Antibacterial Discovery. Escano J; Ravichandran A; Salamat B; Smith L Appl Environ Microbiol; 2017 Jul; 83(14):. PubMed ID: 28500042 [TBL] [Abstract][Full Text] [Related]
56. Synthesis and antibacterial activity of 5-methylphenanthridium derivatives as FtsZ inhibitors. Liu F; Venter H; Bi F; Semple SJ; Liu J; Jin C; Ma S Bioorg Med Chem Lett; 2017 Aug; 27(15):3399-3402. PubMed ID: 28633894 [TBL] [Abstract][Full Text] [Related]
57. Family of class I lantibiotics from actinomycetes and improvement of their antibacterial activities. Maffioli SI; Monciardini P; Catacchio B; Mazzetti C; Münch D; Brunati C; Sahl HG; Donadio S ACS Chem Biol; 2015 Apr; 10(4):1034-42. PubMed ID: 25574687 [TBL] [Abstract][Full Text] [Related]
58. Synthesis, characterization and in vitro antimicrobial activity of novel sulfonylureas of 15-membered azalides. Krajacić MB; Kujundzić N; Dumić M; Cindrić M; Brajsa K; Metelko B; Novak P J Antibiot (Tokyo); 2005 Jun; 58(6):380-9. PubMed ID: 16156514 [TBL] [Abstract][Full Text] [Related]
59. The antibacterial activity of a new 3-azinomethyl-rifamycin. Strippoli V; Bruzzese T; Galli R; Simonetti N; Tronci N Farmaco Sci; 1988; 43(7-8):619-25. PubMed ID: 3147199 [TBL] [Abstract][Full Text] [Related]
60. Antibacterial oxazolidinones possessing a novel C-5 side chain. (5R)-trans-3-[3-Fluoro-4- (1-oxotetrahydrothiopyran-4-yl)phenyl]-2- oxooxazolidine-5-carboxylic acid amide (PF-00422602), a new lead compound. Poel TJ; Thomas RC; Adams WJ; Aristoff PA; Barbachyn MR; Boyer FE; Brieland J; Brideau R; Brodfuehrer J; Brown AP; Choy AL; Dermyer M; Dority M; Ford CW; Gadwood RC; Hanna D; Hongliang C; Huband MD; Huber C; Kelly R; Kim JY; Martin JP; Pagano PJ; Ross D; Skerlos L; Sulavik MC; Zhu T; Zurenko GE; Prasad JV J Med Chem; 2007 Nov; 50(24):5886-9. PubMed ID: 17988109 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]